Beta Bionics Affirms FY2026 Sales Guidance of $131.000M-$136.000M vs $133.305M Est

Benzinga Newsdesk www.benzinga.com Negative 61.4%

Neg 61.4% Neu 0% Pos 0%

Beta Bionics (NASDAQ:BBNX) affirms FY2026 sales outlook from $131.000 million-$136.000 million to $131.000 million-$136.000 million vs $133.305 million estimate.